Related Experiment Video
Updated: May 7, 2026

08:54
Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow
Published on: May 26, 2023
1.4K
Empowering Portable Age-Related Macular Degeneration Screening: Evaluation of a Deep Learning Algorithm for a
Florian Mickael Savoy1, Divya Parthasarathy Rao2, Jun Kai Toh1
1Medios Technologies, Remidio Innovative Solutions, Singapore.
BMJ Open
|September 5, 2024
Summary
An artificial intelligence (AI) system effectively detects referable age-related macular degeneration (AMD) using smartphone retinal images. This technology offers a promising solution for accessible and affordable AMD screening in underserved populations.
Area of Science:
- Ophthalmology
- Artificial Intelligence
- Medical Imaging
Background:
- Large-scale screening for age-related macular degeneration (AMD) remains a global challenge.
- Smartphone-based retinal imaging offers a potential avenue for accessible eye disease detection.
Purpose of the Study:
- To evaluate the performance of an artificial intelligence (AI) algorithm in detecting referable AMD.
- To assess the efficacy of AI in analyzing images from a portable fundus camera.
Main Methods:
- A retrospective dataset from the Age-Related Eye Disease Study (AREDS) was utilized.
- An AI algorithm was trained and fine-tuned on macula-centric retinal images.
- Performance was evaluated using sensitivity, specificity, and Area Under the Curve (AUC).
Main Results:
- The deep learning (DL) algorithm achieved high sensitivity (93.48%) and specificity (82.33%) on the initial AREDS dataset.
- After fine-tuning, the DL algorithm demonstrated a sensitivity of 91.25% and specificity of 84.18% on images from the target device.
- The AUC remained high, indicating strong diagnostic performance for referable AMD detection.
Conclusions:
- The DL algorithm shows significant promise for detecting referable AMD using smartphone-based imaging.
- This AI-driven approach could facilitate cost-effective and widespread AMD screening, particularly in underserved regions.
- Further validation on diverse populations is warranted to confirm its clinical utility.

